NCT03300362View on ClinicalTrials.gov

Improved Novel VaccIne CombinaTion InflUenza Study

PHASE2TerminatedINTERVENTIONAL
Enrollment

862

Participants

Timeline

Start Date

October 13, 2017

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions
Influenza
Interventions
DRUG

Seasonal influenza vaccine

Seasonal influenza vaccine

DRUG

MVA-NP+M1

Trial vaccine

DRUG

Sodium chloride

Saline placebo

Trial Locations (5)

RG8 7DF

The Boathouse Surgery, Pangbourne

RG40 1XS

Wokingham Medical Centre, Wokingham

OX26 6AT

Bicester Health Centre, Bicester

OX3 7LJ

Centre for Clinical Vaccinology and Tropical Medicine (CCVTM, Oxford

OX28 6JS

Windrush Health Centre, Witney

Sponsors
All Listed Sponsors
collaborator

University of Oxford

OTHER

lead

Barinthus Biotherapeutics

INDUSTRY

NCT03300362 - Improved Novel VaccIne CombinaTion InflUenza Study | Biotech Hunter | Biotech Hunter